Research Article
Volume 4 Issue 1 - 2022
Psychoactive Substance Abuse in Patients with COVID-19 in a at the Addiction Center Hospital Setting (Retrospective Study)
1Department of Psychiatry and Drug Addiction, Azerbaijan State Advanced Training Institute, Baku, Azerbaijan
2Azerbaijan Medical University, department of psychiatry Baku, Azerbaijan
2Azerbaijan Medical University, department of psychiatry Baku, Azerbaijan
*Corresponding Author: Nadir A. Aliyev, Department of Psychiatry and Drug Addiction, Azerbaijan State Advanced Training Institute, Baku, Azerbaijan.
Received: June 26, 2022; Published: July 08, 2022
Abstract
Objective: The literature on psychiatric disorders associated with the coronavirus pandemic is scarce. In publications, indicate increased misuse of psychoactive substance abuse in patients with COVID-19. However, there is not study psychoactive substance abuse in patients with COVID-19 in a at the addiction center hospital setting.
Materials and Methods: 106 case histories were reviewed retrospectively. Participants all men to meeting the 2022 ICD-10-CM criteria psychoactive substance abuse dependence.
Results: The results of the study showed the following distribution of patients: F10x2 Alcohol Dependence syndrome =22 person; F 11.2 Opioid dependence syndrome =16; F 19.2 Mental and behavioral disorders resulting from the use of several drugs and other psychoactive substances at the same time = 68 persons.
Conclusion: The data obtained indicate that patients suffering from F 19.2 suffer most from SOVD-19 Mental and behavioral disorders resulting from the use of several drugs and other psychoactive substances at the same time.
Keywords: Substance abuse; COVID-19; Addiction center Hospital
Introduction
Information for the keywords: psychoactive substance abuse in patients with COVID-19; addiction center hospital; retrospective study engines:
- MEDLINE
- PreMEDLINE
- PubMed Central (PMC)
- http://www.ncbi.nlm.nih.gov/pubmed/
- https://www.ncbi.nlm.nih.gov/pmc/
- The Cochrane Library
- http://www.ema.europa.eu/ema/
- https://scholar.google.com
- https://www.rxlist.com/script/main/hp.asp
- http://www.nejm.org
- https://www.bmj.com
- http://ovid.com/site/index.jsp
However, we did not find any data on the Psychoactive substance abuse in patients with COVID-19 in a at the addiction center hospital setting (Retrospective Study).
Materials and Methods
106 case histories were reviewed retrospectively. Participants all men to meeting the 2022 ICD-10-CM criteria psychoactive substance abuse dependence [1]. Retrospective study 106 (all men) clinical record in Psychoactive substance abuse in patients with COVID-19 in a at the addiction center hospital setting, the Ministry of Health of the Republic of Azerbaijan. The study was carried out from March 2021 to December 2022. The age of the patients ranged from 17 to 65 years. Most of the patients were 25-65 years old. Statistical processing was conducted in accordance with Glantz [2].
Characteristics of the patients are shown in table
| Characteristic | 106 males |
| F 19.2 Mental and behavioral disorders resulting from the use of several drugs and other psychoactive substances at the same time | 68 |
| F10x2 Alcohol Dependence syndrome | 22 |
| F 11.2 Opioid dependence syndrome | 16 |
| Mean age (years) M±m | 43±1,59 |
| Education: | |
| —Primary school | 70 (70%) 30 (30%) |
| —Secondary school | |
| Marital status: | |
| —Never married | 30 (30%) 30 (30%) 40 (42%) |
| — Married | |
| — Divorced or separated | |
| Employment status | 100 (100%) |
| — Unemployed |
The results of the study showed the following distribution of patients: F10x2 Alcohol Dependence syndrome =22 person; F 11.2 Opioid dependence syndrome =16; F 19.2 Mental and behavioral disorders resulting from the use of several drugs and other psychoactive substances at the same time = 68 persons. All patients were not employed.
Discussion
As is known from the literature, researchers mainly studied the prevalence of COVID-19 mainly in outpatients. At the same time, it was found that among mental patients, COVID-19 most often suffer from homeless people and people with mental retardation [3-7].
Currently explain why most of all COVD-19 suffer mental and behavioral disorders resulting from the use of several drugs and other psychoactive substances at the same time, it is very difficult for us. Apparently, this is primarily due to a decrease in immunity in this group of patients. Further research is needed in this direction.
Conclusion
The data obtained indicate that patients suffering from F 19.2 suffer most from COVID-19 Mental and behavioral disorders resulting from the use of several drugs and other psychoactive substances at the same time. Currently explain why most of all COVD-19 suffer mental and behavioral disorders resulting from the use of several drugs and other psychoactive substances at the same time, it is very difficult for us.
The limitation of our work is as follows: 1) it is necessary to carry out such studies in many centers; 2) similar research needs to be carried out on the female contingent; 3) on a large clinical material.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
Author Disclosure Information
The authors declare that the article is submitted on behalf of all authors. None of the material in the article has been published previously in any form and none of the material is currently under consideration for publication elsewhere other than noted in the cover letter to the editor. Authors declare no financial and personal relationship with other people or organizations that could inappropriately influence this work. All authors contributed to and have approved the final article. The authors declare no conflicts of interest. No sponsor provided funding for this study.
The authors declare that the article is submitted on behalf of all authors. None of the material in the article has been published previously in any form and none of the material is currently under consideration for publication elsewhere other than noted in the cover letter to the editor. Authors declare no financial and personal relationship with other people or organizations that could inappropriately influence this work. All authors contributed to and have approved the final article. The authors declare no conflicts of interest. No sponsor provided funding for this study.
Acknowledgments
The authors would like to thank the team of doctors of the addiction center hospital setting, Especially Ms. Sona Khudaverdiyeva.
The authors would like to thank the team of doctors of the addiction center hospital setting, Especially Ms. Sona Khudaverdiyeva.
References
- The ICD-10 Classification of Mental and Behavioural Disorders Diagnostic criteria for research World Health Organization Geneva (2022) ICD-10-CM criteria.
- Glantz Stanton Primer of Biostatistics. Seventh Edition. 2011. McGraw-Hill: New York. 320 p.
- Aliyev NA and Aliyev ZN. (2020). Mental Disorders Caused by the COVID-19 Pandemic. A Mental Disorders Caused by the COVID-19 Pandemic. Ann Psychiatry Ment Health 8(2): 1151.
- Aliyev NA and Aliyev ZN. Clinical Features of a Depressive Episodein People Who Had and Haven’tHad Covid-19. Adv Neur Neur Sci. 4 (2): 1-4.
- Nadir A Aliyev, Zafar N Aliyev. (2021). Alternative Treatment of Anxiety Disorders During Covid-19 Pandemic Which Snepco. Clinical Psychology and Mental Health Care, 2(4).
- Nadir A Aliyev and Zafar N Aliyev. (2021). Treatment of Alcohol Dependence in the Context of the COVID-19 Pandemic. Jdrug Addi Ther Volume2(1):1-4.
- NA Aliyev, ZN Aliyev, (2008). “Valproate (depakine-chrono) in the acute treatment of outpatients with generalized anxiety disorder without psychiatric comorbidity: randomized, double-blind placebo-controlled study. Journal of Clinical and Biomedical Research, 1(1).
Citation: Nadir A. Aliyev and Zafar N Aliyev. (2022). Psychoactive Substance Abuse in Patients with COVID-19 in a at the Addiction Center Hospital Setting (Retrospective Study). Journal of Brain and Neurological Disorders 4(1).
Copyright: © 2022 Nadir A. Aliyev. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.